<!DOCTYPE html>
<html lang="zh-tw">
  <head>
   <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta name="description" content="">
    <meta name="author" content="">
    <link rel="icon" href="../../favicon.ico">

    <title>林亮音 教授</title>

    <!-- Bootstrap core CSS -->
    <link href="../bootstrap.min.css" rel="stylesheet">


    <!-- Just for debugging purposes. Don't actually copy these 2 lines! -->
    <!--[if lt IE 9]><script src="../../assets/js/ie8-responsive-file-warning.js"></script><![endif]-->
    <script src="../ie-emulation-modes-warning.js"></script>
    

    <!-- HTML5 shim and Respond.js for IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/html5shiv/3.7.2/html5shiv.min.js"></script>
      <script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
    <![endif]-->

    <!-- Custom styles for this template -->
    <link href="../carousel.css" rel="stylesheet">
    <link href="./personal.css" rel="stylesheet">
    <!-- maxCDN -->
    <!-- <link rel="stylesheet" href="http://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/css/bootstrap.min.css"> -->



    
  </head>



<body>
    

    <nav id = "navBar1" class="navbar navbar-default navbar-fixed-top">
        <div class="container">
        <div class="navbar-header">
          
            <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>                        
            </button>
            
            <img  id = "logo" src="logo4.png">                  
        </div>
        
        <div class="collapse navbar-collapse" id = "myNavbar">
          <ul class="nav navbar-nav " id = "barItem">

            <li id = "barItem1" ><a  href="./index.html" data-toggle="collapse" data-target="#myNavbar.in"><b>回首頁</b></a></li>
            <li id = "barItem2"><a  href="./history.html" data-toggle="collapse" data-target="#myNavbar.in"><b>關於醫技系</b></a></li>
            <li id = "barItem3"><a href="http://ntumtnews.blogspot.tw/" data-toggle="collapse" data-target="#myNavbar.in"><b>最新消息</b></a></li> 
            <li id = "barItem4"><a href="./faculty.html" data-toggle="collapse" data-target="#myNavbar.in"><b>教職員工</b></a></li> 
            <li id = "barItem5"><a href="#" data-toggle="collapse" data-target="#myNavbar.in"><b>招生專區</b></a></li> 
            <li id = "barItem6"><a href="#" data-toggle="collapse" data-target="#myNavbar.in"><b>學生</b></a></li> 
            <li id = "barItem7"><a href="#" data-toggle="collapse" data-target="#myNavbar.in"><b>系友</b></a></li> 
            <li id = "barItem8"><a href="#" data-toggle="collapse" data-target="#myNavbar.in"><b>共同儀器</b></a></li> 
            <li id = "barItem9"><a href="#" data-toggle="collapse" data-target="#myNavbar.in"><b>常用表單</b></a></li> 


          </ul>
        </div>
        <!-- <br> -->
      </div>
    </nav>


    <div class = "row" id = "personalRow3">
        <div class = "col-md-4 ">
            <br><br><br>
            <img id = "teacherImg" src="./lilin.jpg" class="img-rounded" alt="Cinque Terre" >
            <br>
            <br>
        </div>                  
        <div  class = "col-md-8 ">
            <br>
            <p id = "teacherName"><b>林亮音 系主任</b></p>
            <div id = "teacherInfo">
                <b>學歷 </b><br>
				台大醫事技術學系 理學士<br>
				台大醫學院生化所 碩士<br>
				台大醫學院生化所 博士<br><br>
                <b>職稱 </b><br>
				台大醫學院醫學檢驗暨生物技術學系 教授<br>
				台大醫院檢驗醫學部 兼任研究員<br><br>
                <b>研究主題 </b><br>
				<div>
				我的主要研究興趣在於血液學相關的領域．目前著重在急性骨髓性<br>
				白血病於基因體、表觀基因體及蛋白體的研究，包括：基因變異的分析、<br>甲基化基因圖譜的建立、以及與血管增生相關之因子的蛋白量變化。<br>這些研究成果不僅有臨床診斷上的價值也能預測藥物治療的效果。<br>未來更可以成為標靶治療的標的。
				</div><br>

				目前進行中的研究主題<br>
				1. 針對血癌之新穎標靶治療藥物的開發並探討其作用機轉<br>
				2. 建立白血病的斑馬魚模式,了解致病機轉外,可以作為未來篩選有效藥物的工具<br><br>	

				<b>授課科目</b><br>
				血液學、血庫學、醫學分子檢驗學<br><br>
			
                <b>聯絡方式 </b><br>
				E-mail <a href = "mailto:lilin@ntu.edu.tw">lilin@ntu.edu.tw </a><br>
				連絡電話 02-23123456轉66913或67342<br><br><br><br>
            </div>
        </div>    

    <br>

    </div>

    <div class="row" id = "personalRow4">
        <div class="col-md-1"></div>
        <div class="col-md-10" id = "paper"><br><br>
            <b id = "paperTitle"> 論文發表(2005-now)</b>
            <p id = "paperContent">
				<b> Hematology: </b><br>
				1. Ko YC, Fang WH, Lin TC, Hou HA, Chen CY, Tien HF, Lin LI*(correspondent). MicroRNA let-7a-3 gene methylation is associated with karyotyping CEBPA promoter methylation and survival in acute myeloid leukemia. Leuk Res 38: 625-631, 2014.<br>
                2. Hou HA, Lin YC, Kuo YY, Chou WC, Lin CC, Liu CY, Chen CY, Lin LI, Tseng MH, Huang CF, Chiang YC, Liu MC, Liu CS, Tang JL, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Tien HF. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution. Ann Hematol 2014 Sep 21.<br>
                3. Hou HA, Lin CC, Chou WC, Liu CY, Chen CY, Tang JL, Lai YJ, Tseng MH, Huang CF, Chiang YC, Lee FY, Kuo YY, Lee MC, Liu MC, Liu CW, Lin LI, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Tien HF. Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia. Leukemia 28: 50-58, 2014.<br>
                4. Hou HA, Kuo YY, Liu CY, Chou WC, Lee MC, Chen CY, Lin LI, Tseng MH, Huang CF, Chiang YC, Lee FY, Liu MC, Liu CW, Tang JL, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Tien HF.DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications. Blood. 2012 Jan 12;119(2):559-68.<br>
                5. Lin TC, Jiang SS, Chou WC, Hou HA, Lin YM, Chang CL, Hsu CA, Tien HF, Lin LI*.Rapid assessment of the heterogeneous methylation status of CEBPA in patients with acute myeloid leukemia by using high-resolution melting profile. J Mol Diagn. 2011 Sep;13(5):514-9.<br>
                6. Lin TC, Hou HA, Chou WC, Ou DL, Yu SL, Tien HF, Lin LI*.CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia. Leukemia. 2011 Jan;25(1):32-40.<br>
                7. Chou WC, Hou HA, Liu CY, Chen CY, Lin LI, Huang YN, Chao YC, Hsu CA, Huang CF, Tien HF. Sensitive measurement of quantity dynamics of FLT3 internal tandem duplication at early time points provides prognostic information. Ann Oncol. 2011 Mar;22(3):696-704.<br>
                8. Hou HA, Huang TC, Lin LI, Liu CY, Chen CY, Chou WC, Tang JL, Tseng MH, Huang CF, Chiang YC, Lee FY, Liu MC, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Tien HF. WT1 mutation in 470 adult patients with acute myeloid<br>
                leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system. Blood. 2010 Jun 24;115(25):5222-31.<br>
                9. Tang JL, Hou HA, Chen CY, Liu CY, Chou WC, Tseng MH, Huang CF, Lee FY, Liu MC, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Lin LI*, Tien HF*. AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations. Blood. 2009 Dec 17;114(26):5352-61.<br>
                10. Hou HA, Lin LI, Chen CY, Tien HF. Reply to 'Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis'. Br J Cancer. 2009 Aug 18;101(4):738-40.<br>
                11. Chou WC, Chen CY, Hou HA, Lin LI, Tang JL, Yao M, Tsay W, Ko BS, Wu SJ, Huang SY, Hsu SC, Chen YC, Huang YN, Tseng MH, Huang CF, Tien HF. Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients. Leukemia. 2009 Jul;23(7):1303-10.<br>
                12. Lee CY, Tien HF, Hou HA, Chou WC, Lin LI*. Marrow osteopontin level as a prognostic factor in acute myeloid leukaemia. Br J Haematol. 2008 May;141(5):736-9.<br>
                13. Hou HA, Chou WC, Lin LI, Chen CY, Tang JL, Tseng MH, Huang CF, Chiou RJ, Lee FY, Liu MC, Tien HF. Characterization of acute myeloid leukemia with PTPN11 mutation: the mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD. Leukemia. 2008 May;22(5):1075-8.<br>
                14. Hou HA, Chou WC, Lin LI, Tang JL, Tseng MH, Huang CF, Yao M, Chen CY, Tsay W, Tien HF. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia. Leuk Res. 2008 Jun;32(6):904-12.<br>
                15. Chen CY, Lin LI, Tang JL, Ko BS, Tsay W, Chou WC, Yao M, Wu SJ, Tseng MH, Tien HF. RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome. Br J Haematol. 2007 Nov;139(3):405-14.<br>
                16. Lee CY, Tien HF, Hu CY, Chou WC, Lin LI*. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia. Br J Cancer. 2007 Oct 8;97(7):877-82.<br>
                17. Lin LI*, Lin TC, Chou WC, Tang JL, Lin DT, Tien HF. A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias. Leukemia. 2006 Oct; 20(10): 1899-903.<br>
                18. Chen CY, Lin LI, Tang JL, Tsay W, Chang HH, Yeh YC, Huang CF, Chiou RJ, Yao M, Ko BS, Chen YC, Lin KH, Lin DT, Tien HF. Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome. Leukemia. 2006 Jun;20(6):1155-8.<br>
                19. Chou WC, Tang JL, Lin LI, Yao M, Tsay W, Chen CY, Wu SJ, Huang CF, Chiou RJ, Tseng MH, Lin DT, Lin KH, Chen YC, Tien HF. Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution. Cancer Res. 2006 Mar 15;66(6):3310-6.<br>
                20. Lin LI, Chen CY, Lin DT, Tsay W, Tang JL, Yeh YC, Shen HL, Su FH, Yao M, Huang SY, Tien HF. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells. Clin Cancer Res. 2005 Feb 15;11(4):1372-9.<br>
				<b>Oncology:</b>
				1. Tsai JH, Lin YL, Cheng YC, Chen CC, Lin LI, Tseng LH, Cheng ML, Liau JY, Jeng YM. Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma. Modern Pathology, 2014 Aug 1. doi: 10.1038/modpathol.2014.96.<br>
                2. Huang HN, Lin MC, Tseng LH, Chiang YC, Lin LI, Lin YF, Huang HY, Kuo KT. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression and ARID1A expression. Histopathology 2014 Sep 6. doi: 10.1111/his.12543<br>
                3. Lin YL, Liang YH, Tsai JH, Liau JY, Liang JT, Lin BR, Hung JS, Lin LI, Tseng LH, Chang YL, Yeh KH, Cheng AL. Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients. PLoS One 9: e86789, 2014.<br>
                4. Lin YL, Liau JY, Yu SC, Tseng LH, Lin LI, Liang JT, Lin BR, Hung JS, Chang YL, Yeh KH, Cheng AL. Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer. Transl Oncol 6: 363-369, 2013.<br>
                5. Ou DL, Lee BS, Chang YC, Lin LI, Liou JY, Hsu C, Cheng AL. Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathway. PLoS One 2013;<br>
                6. Lin TC, Chen YR, Kensicki E, Kong M, Li Y, Mohney RP, Shen HM, Stilses B, Mizushima N, Lin LI, Ann DK. Autophagy: resetting glutamine-dependent metabolism and oxygen consumption. Autophagy 8: 1477-1493, 2012.<br>
                7. Lin YL, Liau JY, Yu SC, Ou DL, Lin LI, Tseng LH, Chang YL, Yeh KH, Cheng AL. KRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cells. PLoS One 7: e50701, 2012.<br>
                8. Ko YC, Chang CL, Chien HF, Wu CH, Lin LI*. Resveratrol enhances the expression of death receptor Fas/CD95 and induces differentiation and apoptosis in anaplastic large-cell lymphoma cells. Cancer Lett. 2011 Oct 1;309(1):46-53.<br>
                9. Ou DL, Shen YC, Yu SL, Chen KF, Yeh PY, Fan HH, Feng WC, Wang CT, Lin LI, Hsu C, Cheng AL. Induction of DNA damage-inducible gene GADD45beta contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells. Cancer Res. 2010 Nov 15;70(22):9309-18.<br>
                10. Ou DL, Chien HF, Chen CL, Lin TC, Lin LI*. Role of Twist in head and neck carcinoma with lymph node metastasis. Anticancer Res. 2008 Mar-Apr; 28(2B): 1355-9.<br>
                11. Huang CP, Fang WH, Lin LI, Chiou RY, Kan LS, Chi NH, Chen YR, Lin TY, Lin SB. Anticancer activity of botanical alkyl hydroquinones attributed to topoisomerase II poisoning. Toxicol Appl Pharmacol. 2008 Mar 15;227(3):331-8.<br>
                12. Ou DL, Chen CL, Lin SB, Hsu CH, Lin LI*. Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy. J Pathol. 2006 Nov;210(3):363-73.<br>
				13. Chang UM, Li CH, Lin LI, Huang CP, Kan LS, Lin SB. Ganoderiol F, a ganoderma triterpene, induces senescence in hepatoma HepG2 cells. Life Sci. 2006 Aug 15;79(12):1129-39.
				<b>Blood Bank</b>
				1. Pai SC, Burnouf T, Chen JW, Lin LI*. Human platelet antigen alleles in 998 Taiwanese blood donors determined by sequence-specific primer polymerase chain reaction. BioMed Res Int 2013, 2013: 973-789.<br>
            2. Pai SC, Lo SC, Lin Tsai SJ, Chang JS, Lin DT, Lin KS, Lin LI*. Epitope-based matching for HLA-alloimmunized platelet refractoriness in patients with hematologic diseases. Transfusion. 2010 Nov;50(11):2318-27.         
        </div>
        <div class="col-md-1>"></div>
    </div>    







            
    <!-- Bootstrap core JavaScript
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.1/jquery.min.js"></script>
    <script src="./bootstrap.min.js"></script>
    <!-- IE10 viewport hack for Surface/desktop Windows 8 bug -->
    <script src="./ie10-viewport-bug-workaround.js"></script>
    <script src="./docs.min.js"></script>
</body>
</html>
